← back to search

Nadja Siebert

Humboldt-Universität zu Berlin · DE
Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Autoimmune Neurological Disorders and Treatments, and Systemic Lupus Erythematosus Research.
h-index
17
citations
1,081
works
34
NIH funding
primary concept
email

Recent publications

Machine Learning Identifies Microbiome and Clinical Predictors of Sustained Weight Loss Following Prolonged Fasting
medRxiv 2025cited by 1position: lastdoi
Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort
EClinicalMedicine 2023cited by 91position: middledoi
Costs and health-related quality of life in patients with NMO spectrum disorders and MOG-antibody-associated disease: CHANCE(NMO) study
MDC Repository (Max-Delbrueck-Center for Molecular Medicine) 2022cited by 28position: middle
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
Journal of Neuroinflammation 2021cited by 84position: middledoi
Pain, depression, and quality of life in adults with MOG‐antibody–associated disease
European Journal of Neurology 2021cited by 38position: middledoi
C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD
Journal of Neuroimmunology 2021cited by 31position: middledoi
Anti-aquaporin 4 IgG Is Not Associated With Any Clinical Disease Characteristics in Neuromyelitis Optica Spectrum Disorder
Frontiers in Neurology 2021cited by 28position: lastdoi
Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study
NeuroImage Clinical 2021cited by 16position: middledoi
Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells
Neurotherapeutics 2021cited by 9position: middledoi
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders
Multiple Sclerosis Journal - Experimental Translational and Clinical 2021cited by 8position: middledoi
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
Journal of Neuroinflammation 2020cited by 166position: middledoi
Prodromal headache in MOG-antibody positive optic neuritis
Multiple Sclerosis and Related Disorders 2020cited by 67position: middledoi
Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders
Multiple Sclerosis and Related Disorders 2020cited by 24position: middledoi
Anti-MOG antibody–associated disorders: differences in clinical profiles and prognosis in Japan and Germany
Journal of Neurology Neurosurgery & Psychiatry 2020cited by 24position: middledoi
Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
Frontiers in Neurology 2020cited by 23position: middledoi
Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders
European Radiology 2020cited by 17position: middledoi
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders
Neurology 2019cited by 47position: middledoi
Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders
Journal of Neurology Neurosurgery & Psychiatry 2019cited by 28position: middledoi
Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory study
Brain Communications 2019cited by 22position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Friedemann Paul · Max Delbrück Center16 papers (2019–2025)Judith Bellmann–Strobl · Humboldt-Universität zu Berlin14 papers (2019–2023)Susanna Asseyer · Humboldt-Universität zu Berlin12 papers (2019–2021)Klemens Ruprecht · Heidelberg University12 papers (2019–2021)Alexander U. Brandt · Eli Lilly (United States)10 papers (2019–2021)Sven Jarius · Heidelberg University7 papers (2020–2021)Claudia Chien · Humboldt-Universität zu Berlin7 papers (2019–2021)Hanna Zimmermann · German Center for Diabetes Research7 papers (2019–2021)Joseph Kuchling · Charité - Universitätsmedizin Berlin7 papers (2019–2021)Michael Scheel · Charité - Universitätsmedizin Berlin6 papers (2019–2021)Frederike Cosima Oertel · Max Delbrück Center6 papers (2019–2021)Athina Papadopoulou · University of Basel4 papers (2019–2021)M. Mallar Chakravarty · University Health Network3 papers (2019–2021)Graham Cooper · Humboldt-Universität zu Berlin3 papers (2020–2021)Stefano Magon · Technical University of Munich3 papers (2019–2021)Ankelien Duchow · Max Delbrück Center3 papers (2021–2021)Jens Wuerfel · Roche (Switzerland)3 papers (2019–2021) · 2 papers (2020–2021)Ingo Kleiter · Dentsply Sirona (United States)2 papers (2021–2021)Kazuo Sugimoto · Beijing University of Chinese Medicine2 papers (2020–2021)